Healthcare provider profile · identity verified

Jun Ta Huang, DO

Family Practice · BALDWIN PARK, CA · NPI 1447322771

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	893	350
Lisinopril	Lisinopril	567	219
Losartan Potassium	Losartan Potassium	463	176
Simvastatin	Simvastatin	437	156
Amlodipine Besylate	Amlodipine Besylate	318	141
Metformin Hcl	Metformin Hcl	315	120
Levothyroxine Sodium	Levothyroxine Sodium	261	95
Atenolol	Atenolol	243	84
Terazosin Hcl	Terazosin Hcl	219	83
Hydrochlorothiazide	Hydrochlorothiazide	215	83
Metoprolol Tartrate	Metoprolol Tartrate	181	76
Omeprazole	Omeprazole	178	97
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	177	65
Glipizide	Glipizide	170	68
Alendronate Sodium	Alendronate Sodium	169	69
Meloxicam	Meloxicam	148	108
Potassium Chloride	Potassium Chloride	146	63
Gabapentin	Gabapentin	144	63
Trazodone Hcl	Trazodone Hcl	132	44
Albuterol Sulfate Hfa	Albuterol Sulfate	122	89
Metformin Hcl Er	Metformin Hcl	119	51
Tamsulosin Hcl	Tamsulosin Hcl	114	46
Allopurinol	Allopurinol	110	45
Furosemide	Furosemide	109	55
Humulin N Kwikpen	Insulin Nph Human Isophane	103	26
Rosuvastatin Calcium	Rosuvastatin Calcium	100	48
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	93	32
Humulin N	Insulin Nph Human Isophane	84	29
Duloxetine Hcl	Duloxetine Hcl	83	37
Finasteride	Finasteride	79	28
Hydralazine Hcl	Hydralazine Hcl	79	37
Pantoprazole Sodium	Pantoprazole Sodium	77	31
Pradaxa	Dabigatran Etexilate Mesylate	77	28
Ibuprofen	Ibuprofen	76	54
Prednisone	Prednisone	68	63
Azelastine Hcl	Azelastine Hcl	66	30
Famotidine	Famotidine	65	33
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	64	25
Clopidogrel	Clopidogrel Bisulfate	63	29
Nifedipine Er	Nifedipine	59	22
Spiriva Respimat	Tiotropium Bromide	53	11
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	53	20
Morphine Sulfate Er	Morphine Sulfate	52	suppressed
Carvedilol	Carvedilol	47	18
Tramadol Hcl	Tramadol Hcl	47	18
Ciclopirox	Ciclopirox	46	34
Hydrocortisone	Hydrocortisone	46	28
Triamcinolone Acetonide	Triamcinolone Acetonide	46	29
Sertraline Hcl	Sertraline Hcl	44	20
Spironolactone	Spironolactone	41	16
Doxycycline Monohydrate	Doxycycline Monohydrate	38	36
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	37	33
Ezetimibe	Ezetimibe	37	19
Lactulose	Lactulose	37	11
Mirtazapine	Mirtazapine	37	17
Colchicine	Colchicine	35	20
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	34	16
Cephalexin	Cephalexin	33	32
Jardiance	Empagliflozin	32	14
Buspirone Hcl	Buspirone Hcl	31	14
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	29	29
Bisoprolol Fumarate	Bisoprolol Fumarate	29	16
Lorazepam	Lorazepam	29	17
Pravastatin Sodium	Pravastatin Sodium	28	suppressed
Propranolol Hcl	Propranolol Hcl	28	15
Escitalopram Oxalate	Escitalopram Oxalate	27	11
Fluticasone Propionate	Fluticasone Propionate	27	11
Humulin R	Insulin Regular, Human	27	suppressed
Lovastatin	Lovastatin	27	suppressed
Topiramate	Topiramate	26	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	23
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Warfarin Sodium	Warfarin Sodium	23	suppressed
Alprazolam	Alprazolam	22	suppressed
Breyna	Budesonide/Formoterol Fumarate	22	suppressed
Montelukast Sodium	Montelukast Sodium	22	suppressed
Citalopram Hbr	Citalopram Hydrobromide	21	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	21	11
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Lidocaine-Prilocaine	Lidocaine/Prilocaine	20	suppressed
Naproxen	Naproxen	20	18
Paxlovid	Nirmatrelvir/Ritonavir	20	20
Pregabalin	Pregabalin	20	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	19	14
Memantine Hcl	Memantine Hcl	19	13
Clonazepam	Clonazepam	17	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Temazepam	Temazepam	17	suppressed
Alvesco	Ciclesonide	16	12
Amoxicillin	Amoxicillin	16	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	11
Calcitonin-Salmon	Calcitonin,salmon,synthetic	15	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Trospium Chloride	Trospium Chloride	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Eliquis	Apixaban	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	11
Clindamycin Hcl	Clindamycin Hcl	11	11
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Dupixent Syringe	Dupilumab	11	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Nystatin	Nystatin	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error